Alzheimer’s drug
05/02/2017 / By Amy Goodrich
Dangerous Alzheimer’s treatment drug DONEPEZIL being widely prescribed “off-label” was never approved for such uses by the FDA
Donepezil is an acetylcholinesterase inhibitor approved by the Food and Drug Administration (FDA) in the United States to treat Alzheimer’s disease. Since mild cognitive impairment (MCI), or the phase between normal age-related brain decline and dementia, displays similar symptoms to Alzheimer’s, many physicians also prescribe this drug off-label to patients with MCI. Researchers from the […]
1 of 1

Popular Posts

Medicine.News is a fact-based public education website published by Medicine News Features, LLC.

All content copyright © 2018 by Medicine News Features, LLC.

Contact Us with Tips or Corrections

All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.